Steve Bishop's most recent trade in Ashland Inc was a trade of 497 Common Stock Units done . Disclosure was reported to the exchange on June 30, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Ashland Inc | Steven D. Bishop | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2025 | 497 | 3,809 | - | - | Common Stock Units | |
| Ashland Inc | Steven D. Bishop | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2025 | 422 | 3,285 | - | - | Common Stock Units | |
| Ashland Inc | Steven D. Bishop | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jan 2025 | 2,050 | 5,947 | - | - | Restricted Stock Units | |
| Ashland Inc | Bishop Steven D. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2024 | 350 | 2,843 | - | - | Common Stock Units | |
| Ashland Inc | Steve Bishop | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2024 | 287 | 2,479 | - | - | Common Stock Units | |
| Ashland Inc | Steve Bishop | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2024 | 265 | 2,182 | - | - | Common Stock Units | |
| Ashland Inc | Steve Bishop | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Mar 2024 | 257 | 1,909 | - | - | Common Stock Units | |
| Ashland Inc | Bishop Steve | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2024 | 1,897 | 3,828 | - | - | Restricted Stock Units | |
| Ashland Inc | Bishop Steve | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Dec 2023 | 297 | 1,646 | - | - | Common Stock Units | |
| Ashland Inc | Steve Bishop | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Sep 2023 | 307 | 1,344 | - | - | Common Stock Units | |
| Ashland Inc | Steve Bishop | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2023 | 5 | 1,037 | - | - | Common Stock Units | |
| Ashland Inc | Steve Bishop | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2023 | 288 | 1,030 | - | - | Common Stock Units | |
| Ashland Inc | Steve Bishop | Director | Other type of transaction at price $ 0.00 per share. | 31 Mar 2023 | 243 | 742 | - | - | Common Stock Units | |
| Ashland Inc | Steve Bishop | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2023 | 1,365 | 1,899 | - | - | Restricted Stock Units | |
| Ashland Inc | Steve Bishop | Director | Other type of transaction at price $ 0.00 per share. | 30 Dec 2022 | 232 | 497 | - | - | Common Stock Units | |
| Ashland Inc | Steve Bishop | Director | Other type of transaction at price $ 0.00 per share. | 30 Sep 2022 | 263 | 263 | - | - | Common Stock Units | |
| Ashland Inc | Steve Bishop | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2022 | 531 | 531 | - | - | Restricted Stock Units | |
| P&G | Steve Bishop | CEO - Health Care | Exercise or conversion of derivative security received from the company (such as an option) at price $ 78.66 per share. | 11 May 2021 | 60,000 | 118,677 (0%) | 0% | 78.7 | 4,719,600 | Common Stock |
| P&G | Steve Bishop | CEO - Health Care | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 May 2021 | 60,000 | 39,797 | - | - | Stock Option (Right to Buy) | |
| P&G | Steve Bishop | CEO - Health Care | Sale of securities on an exchange or to another person at price $ 138.50 per share. | 11 May 2021 | 60,000 | 58,677 (0%) | 0% | 138.5 | 8,310,000 | Common Stock |
| P&G | Steve Bishop | CEO - Health Care | Sale of securities on an exchange or to another person at price $ 125.77 per share. | 26 Feb 2021 | 3,173 | 58,677 (0%) | 0% | 125.8 | 399,073 | Common Stock |
| P&G | Steve Bishop | CEO - Health Care | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2021 | 109 | 1,993 | - | - | Restricted Stock Units | |
| P&G | Steve Bishop | CEO - Health Care | Payment of exercise price or tax liability using portion of securities received from the company at price $ 137.02 per share. | 15 Dec 2020 | 233 | 61,762 (0%) | 0% | 137.0 | 31,925 | Common Stock |
| P&G | Steve Bishop | CEO - Health Care | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2020 | 134 | 9,014 | - | - | Series A Preferred Stock | |
| P&G | Steve Bishop | CEO - Health Care | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2020 | 97 | 1,883 | - | - | Restricted Stock Units | |
| P&G | Steve Bishop | CEO - Health Care | Payment of exercise price or tax liability using portion of securities received from the company at price $ 137.61 per share. | 15 Dec 2020 | 72 | 61,995 (0%) | 0% | 137.6 | 9,908 | Common Stock |
| P&G | Steve Bishop | CEO - Health Care | Exercise or conversion of derivative security received from the company (such as an option) at price $ 137.61 per share. | 15 Dec 2020 | 72 | 62,067 (0%) | 0% | 137.6 | 9,908 | Common Stock |
| P&G | Steve Bishop | CEO - Health Care | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2020 | 72 | 1,090 | - | - | Restricted Stock Units | |
| P&G | Steve Bishop | CEO - Health Care | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2020 | 78,893 | 78,893 | - | - | Stock Option (Right to Buy) | |
| P&G | Steve Bishop | CEO - Health Care | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Aug 2020 | 38,399 | 79,608 (0%) | 0% | 0 | Common Stock | |
| P&G | Steve Bishop | CEO - Health Care | Sale of securities on an exchange or to another person at price $ 136.53 per share. | 18 Aug 2020 | 17,693 | 61,915 (0%) | 0% | 136.5 | 2,415,569 | Common Stock |
| P&G | Steve Bishop | CEO - Health Care | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Aug 2020 | 95 | 1,786 | - | - | Restricted Stock Units | |
| P&G | Steve Bishop | CEO - Health Care | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Aug 2020 | 1,163 | 1,163 | - | - | Restricted Stock Units | |
| P&G | Steve Bishop | CEO - Health Care | Exercise or conversion of derivative security received from the company (such as an option) at price $ 76.18 per share. | 31 Jul 2020 | 68,452 | 109,576 (0%) | 0% | 76.2 | 5,214,673 | Common Stock |
| P&G | Steve Bishop | CEO - Health Care | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jul 2020 | 68,452 | 0 | - | - | Stock Option (Right to Buy) | |
| P&G | Steve Bishop | CEO - Health Care | Sale of securities on an exchange or to another person at price $ 130.00 per share. | 31 Jul 2020 | 68,452 | 41,124 (0%) | 0% | 130 | 8,898,760 | Common Stock |
| P&G | Steve Bishop | CEO - Health Care | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jul 2020 | 113 | 1,690 | - | - | Restricted Stock Units |